Business

Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

Successful execution of new strategy for sustainable and profitable growth leading to changing revenue mix with strong demand for Evotec's differentiated platforms High-margin technology license revenues expected to have a stronger impactthan anticipated ...

articleEvotec SeJuly 21, 20252/company/evotec-se/news/evotec-adjusts-revenue-guidance-and-confirms-profit-guidance-anticipating-a-more-profitable-revenue-mix
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

About this update from Evotec Se

[{"type":"list","items":[{"val":[{"type":"text","content":"Successful execution of new strategy for sustainable and profitable growth leading to changing revenue mix with strong demand for Evotec's differentiated platforms","length":167,"tagName":"p"}]},{"val":[{"type":"text","content":"High-margin technology license revenues expected to have a stronger impactthan anticipated","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"Significant cost optimization in excess of initial targets from Priority Reset","length":78,"tagName":"p"}]},{"val":[{"type":"text","content":"Shared R&D base businesscontinues to navigate in a challenging market environment","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"H1 2025 Group revenues below expectations; adj. EBITDA broadly in line with expectations","length":88,"tagName":"p"}]},{"val":[{"type":"text","content":"Revenue guidance adjusted; R&D and adjusted EBITDA guidance unchanged, reflecting improved revenue mix and cost discipline","length":126,"tagName":"p"}]},{"val":[{"type":"text","content":"Evotec confirms itsOutlook 2028","length":31,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":665,"olType":false},{"type":"text","content":"HAMBURG, DE / ACCESS Newswire / July 21, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that it has updated its revenue guidance for the fiscal year 2025. R&D and adjusted EBITDA related guidance elements remain unaffected.","length":290,"tagName":"p"},{"type":"text","content":"For the current fiscal year, the Company expects revenues in the range of € 760 - 800 m (versus previously € 840 - 880 m; 2024: € 797.0 m);","length":139,"tagName":"p"},{"type":"text","content":"R&D expenditures are expected in a range of € 40 - 50 m (unchanged; 2024: € 50.8 m);","length":88,"tagName":"p"},{"type":"text","content":"Adjusted EBITDA 1 is expected to reach € 30 - 50 m (unchanged; 2024: € 22.6 m).","length":79,"tagName":"p"},{"type":"text","content":"Outlook 2028 remains unchanged with a targeted Group revenue CAGR 2024-2028 in a range of 8 - 12% and an expected adj. EBITDA margin above 20% by 2028.","length":151,"tagName":"p"},{"type":"text","content":"1 Excluding potential costs related to the transformation program in 2025CAGR: Compound annual growth rate","length":107,"tagName":"p"...

More updates from Evotec Se

Evotecprofitable growthFrankfurt Stock ExchangeEBITDA marginACCESS Newswirerevenue guidance